ImpediMed Ltd. | Ownership
Companies that own ImpediMed Ltd.
Allan Gray Australia Pty Ltd.
63,713,308
16.8%
7,625,073
0.73%
10/25/2017
Kinetic Investment Partners Pty Ltd.
24,265,677
6.4%
4,962,910
12.43%
02/13/2018
Paradice Investment Management Pty Ltd.
22,763,711
6.01%
3,909,909
0.56%
11/13/2017
FIL Investment Management (Hong Kong) Ltd.
20,139,860
5.31%
0
0.03%
10/25/2017
Macquarie Investment Management Ltd.
13,359,696
3.53%
3,803,283
0.09%
08/08/2018
Macquarie Bank Ltd.
10,137,226
2.68%
227,000
0.23%
08/08/2018
FIL Investment Advisors (UK) Ltd.
4,616,220
1.22%
0
0%
10/25/2017
FIL Investment Management (Singapore) Ltd.
3,953,092
1.04%
0
0.02%
08/04/2017
FIL Investment Management (Australia) Ltd.
3,236,828
0.85%
0
0.02%
10/25/2017
Vanguard Investments Australia Ltd.
2,614,894
0.69%
292,689
0%
07/31/2018
| Address |
50 Parker Court
Pinkenba Queensland (QLD) 4008
Australia
|
|
Employees
|
- |
| Website |
http://www.impedimed.com |
| Updated |
07/08/2019 |
| ImpediMed Ltd. engages in the development and distribution of medical devices using bioimpedance spectroscopy technologies for use in the non-invasive clinical assessment and monitoring of human disorders and diseases. It operates through the Medical and Test and Measurement segments. The Medical segment supplies non-invasive medical devices to two under-served markets: aiding in the subclinical assessment of individuals at risk of secondary lymphoedema; and the monitoring of body composition and hydration. |
